SPRY
ARS Pharmaceuticals, Inc.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| SCHEDULE 13G | 7/27/2026 | View on SEC |
| 8-K | 7/17/2026 | View on SEC |
| SCHEDULE 13G/A | 7/14/2026 | View on SEC |
| 8-K | 7/7/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SPRY |
| Company Name | ARS Pharmaceuticals, Inc. |
| CIK | 1671858 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 858-771-9307 |